BAYER AG

🇩🇪Germany

Country: 🇩🇪Germany

Ownership: Public

Established: 1863-08-01

Employees: 99.7K

Market Cap: $30.1B

Website: http://www.bayer.com

Clinical Trials

A Study to Assess the Effectiveness of Aflibercept in Routine Clinical Practice in Patients With Diabetic Macular Oedema

Completed

Conditions: Macular Edema

Interventions: Drug: Eylea (Aflibercept, VEGF Trap-Eye, BAY86-5321)

First Posted Date: 2016-07-29

Last Posted Date: 2021-11-02

Lead Sponsor: Bayer

Target Recruit Count: 750

Registration Number: NCT02850263

Evaluation of Sunscreen During Exercise Under Conditions of Profuse Sweating

Not Applicable

Completed

Conditions: Sunscreening Agent

Interventions: Drug: BAY987517

First Posted Date: 2016-07-22

Last Posted Date: 2018-12-13

Lead Sponsor: Bayer

Target Recruit Count: 15

Registration Number: NCT02842268

A Non-interventional Study to Observe the Computed Tomographic Angiography Image Quality With Different Contrast Media Injection Protocols Under Different Computed Tomography Machines Parameters Setting

Completed

Conditions: Angiography
Multidetector Computed Tomography

Interventions: Drug: Iopromide (Ultravist, BAY86-4877)

First Posted Date: 2016-07-21

Last Posted Date: 2018-10-02

Lead Sponsor: Bayer

Target Recruit Count: 1214

Registration Number: NCT02840903

Outdoor-Use Test for Sunscreen Products in Children Ages 3 to 9 Years Old

Not Applicable

Completed

Conditions: Sunscreening Agent

Interventions: Drug: BAY987517
Drug: Sunscreen Lotion (RB# T78-190B)

First Posted Date: 2016-07-13

Last Posted Date: 2018-12-12

Lead Sponsor: Bayer

Target Recruit Count: 98

Registration Number: NCT02831478

Study Evaluating "Real World" Treatment Pattern in Previously Treated Hemophilia A Patients Receiving KOVALTRY (Octocog Alfa) for Routine Prophylaxis

Completed

Conditions: Hemophilia A, Congenital

Interventions: Biological: Kovaltry (Antihemophilic Factor [Recombinant], BAY81-8973

First Posted Date: 2016-07-13

Last Posted Date: 2023-11-07

Lead Sponsor: Bayer

Target Recruit Count: 313

Registration Number: NCT02830477

Locations: 🇺🇸
East Carolina University - Brody School of Medicine, Greenville, North Carolina, United States
🇺🇸
Hemophilia Center of Western New York, Buffalo, New York, United States
🇺🇸
Children's Rehabilitation Services/ University of South Alabama, Mobile, Alabama, United States

and more 10 locations

Non-interventional, Postauthorization Safety Study of Ventavis for Pulmonary Arterial Hypertension (PAH)

Completed

Conditions: Hypertension, Pulmonary

Interventions: Drug: Ventavis (Iloprost, BAYQ6256)

First Posted Date: 2016-07-07

Last Posted Date: 2024-08-19

Lead Sponsor: Bayer

Target Recruit Count: 282

Registration Number: NCT02825160

Locations: 🇯🇵
Many Locations, Multiple Locations, Japan

Sun Protection Factor Assay (SPF Assay 18677)

Not Applicable

Completed

Conditions: Sunscreening Agent

Interventions: Drug: Coppertone (BAY 987517)

First Posted Date: 2016-07-07

Last Posted Date: 2018-12-13

Lead Sponsor: Bayer

Target Recruit Count: 10

Registration Number: NCT02825017

Examination of Ventavis (Iloprost) Inhalation Behavior Using the I-Neb AAD System in Patients With Pulmonary Arterial Hypertension When Switching the Iloprost Nebulizer Solution for Inhalation From 10 μg/mL (V10) to 20 μg/mL (V20)

Completed

Conditions: Hypertension, Pulmonary

Interventions: Drug: Iloprost,(Ventavis, BAYQ6256)
Device: I-Neb AAD system

First Posted Date: 2016-07-07

Last Posted Date: 2017-03-15

Lead Sponsor: Bayer

Target Recruit Count: 64

Registration Number: NCT02826252

Sun Protection Factor Assay (SPF Assay 18676)

Not Applicable

Completed

Conditions: Sunscreening Agent

Interventions: Drug: Coppertone (BAY 987516)

First Posted Date: 2016-07-07

Last Posted Date: 2018-12-13

Lead Sponsor: Bayer

Target Recruit Count: 10

Registration Number: NCT02825030

Thorough ECG (Electrocardiogram) and Drug Interaction Study With Anetumab Ravtansine and Itraconazole

Phase 1

Completed

Conditions: Medical Oncology

Interventions: Drug: Anetumab ravtansine (BAY94-9343)
Drug: Itraconazole

First Posted Date: 2016-07-06

Last Posted Date: 2020-07-31

Lead Sponsor: Bayer

Target Recruit Count: 63

Registration Number: NCT02824042

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
🇦🇺
Blacktown Cancer & Haematology Centre, Blacktown, New South Wales, Australia
🇫🇷
Centre Georges Francois Leclerc Dijon, Dijon, France

and more 15 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy